A Study to Evaluate Pharmacokinetics, Safety and Tolerability of MEDI0382 in Renal Impairment Subjects
NCT03235375 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 37
Last updated 2018-05-01
Summary
A phase 1 open-label, single-dose study to evaluate the pharmacokinetics (PK), safety, tolerability and immunogenicity of MEDI0382 in subjects with renal impairment.
Conditions
- Renal Insufficiency
Interventions
- DRUG
-
MEDI0382
MEDI0382 administered subcutaneously
Sponsors & Collaborators
-
MedImmune LLC
lead INDUSTRY
Study Design
- Allocation
- NON_RANDOMIZED
- Purpose
- BASIC_SCIENCE
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Max Age
- 85 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2017-10-27
- Primary Completion
- 2018-04-24
- Completion
- 2018-04-24
Countries
- Germany
- New Zealand
Study Locations
More Related Trials
-
A Single Dose Study Investigating the Elimination as Well as the Tolerability of PD 0332334 in Healthy Subjects as Compared to Patients With Impaired Kidney Function.
NCT00721422 ·Status: TERMINATED ·Phase: PHASE1
-
A Renal Impairment Study for PF-04965842
NCT03660241 ·Status: COMPLETED ·Phase: PHASE1
-
A Study to Evaluate ID-085 in People With Mild, Moderate, and Severe Kidney Disease
NCT03913000 ·Status: COMPLETED ·Phase: PHASE1
-
A Study to Learn How the Study Treatment BAY3283142 Taken as Single Dose by Mouth Moves Into, Through, and Out of the Body, How Safe it is, and How it Affects the Body in Participants With Reduced Kidney Function Compared to Participants With Normal Kidney Function of Similar Age, Gender, and Weight
NCT05515432 ·Status: COMPLETED ·Phase: PHASE1
-
Study to Evaluate the Pharmacokinetics, Safety, and Pharmacodynamics of INCB054707 in Participants With Normal and Impaired Renal Function and Participants on Hemodialysis
NCT05624723 ·Status: COMPLETED ·Phase: PHASE1
-
Pharmacokinetics (PK) and Safety of a Single Intravenous (IV) Dose of MK-3866 in Participants With Impaired Renal Function and in Healthy Controls (MK-3866-005)
NCT03259087 ·Status: COMPLETED ·Phase: PHASE1
-
A Study of the Pharmacokinetics and Safety of Varespladib in Subjects With Normal or Impaired Renal Function
NCT01359579 ·Status: TERMINATED ·Phase: PHASE1
-
Study of a Single Intravenous (IV) Dose of MK-3402 in Participants With Impaired Renal Function and in Healthy Controls (MK-3402-004)
NCT04678505 ·Status: TERMINATED ·Phase: PHASE1
-
Pharmacokinetic Assessment of Single-Dose Odanacatib (MK-0822) in Subjects With Severe Renal Insufficiency (MK-0822-067)
NCT01512667 ·Status: COMPLETED ·Phase: PHASE1
-
A Phase I Study to Investigate the Effect of Renal Impairment on the Pharmacokinetics, Safety, and Tolerability of AZD0780
NCT06592482 ·Status: COMPLETED ·Phase: PHASE1
-
Study to Evaluate the Pharmacokinetics, Safety, and Pharmacodynamics of INCB000928 in Participants With Impaired Renal Function and Hemodialysis
NCT05099445 ·Status: COMPLETED ·Phase: PHASE1
-
A Clinical Study of Calderasib (MK-1084) in Participants With Renal Impairment (MK-1084-010)
NCT06814119 ·Status: COMPLETED ·Phase: PHASE1
-
A Study to Evaluate the Effect of Renal Impairment and Dialysis Treatment on the Pharmacokinetics (PK) of a Single Intravenous (IV) TAK-954
NCT03296787 ·Status: COMPLETED ·Phase: PHASE1
-
A Study to Learn How the Body Processes the Study Medicine PF-07328948 in People With Reduced Kidney Function
NCT07315360 ·Status: RECRUITING ·Phase: PHASE1
-
A Study to Assess S-217622 in Participants With Renal Impairment and Healthy Participants
NCT05363215 ·Status: COMPLETED ·Phase: PHASE1
-
PF-04634817 Renal Impairment Study
NCT01791855 ·Status: COMPLETED ·Phase: PHASE1
-
Study to Assess the Effect of Renal Impairment on the Pharmacokinetics of CTP-543
NCT05468749 ·Status: COMPLETED ·Phase: PHASE1
-
A Study of LY3437943 in Healthy Participants and Participants With Impaired Renal Function
NCT05611957 ·Status: COMPLETED ·Phase: PHASE1
-
Single-Dose Study to Evaluate the PKs of Pretomanid in Participants With Renal Impairment Compared to Participants With Normal Renal Function
NCT03896750 ·Status: COMPLETED ·Phase: PHASE1
-
A Study to Evaluate the Pharmacokinetics and Safety of DBPR108 in Subjects With Renal Impairment
NCT04859439 ·Status: COMPLETED ·Phase: PHASE1
-
A Single Dose Study Investigating The Elimination Of PD-0332334 In Patients Receiving Regular Hemodialysis
NCT00730145 ·Status: COMPLETED ·Phase: PHASE1
-
A Study to Investigate the Safety, Tolerability, and Pharmacokinetics of VS 105
NCT03043482 ·Status: COMPLETED ·Phase: PHASE1
-
A Phase 1 Study to Evaluate the Pharmacokinetics of Setmelanotide in Subjects With Varying Degrees of Renal Impairment
NCT04348175 ·Status: COMPLETED ·Phase: PHASE1
-
Study to Evaluate the Effect of Renal Impairment and Dialysis Treatment on the Pharmacokinetics of a Single 3 mg Cytisinicline Dose
NCT05631938 ·Status: COMPLETED ·Phase: PHASE1
-
Pharmacokinetics Of CP-690,550 In Patients With Impaired Renal Function
NCT01740362 ·Status: COMPLETED ·Phase: PHASE1